Company intelligence / Profile preview

Stanley Capital Partners

London, United Kingdom

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Stanley Capital Partners is a European-focused mid‑market private equity firm investing primarily in healthcare, resource efficiency and technology companies; it is an investor, not an operating life science/biotech company.[1][2][5]

Industry: Investors

Partnerships

Grafine Partners (strategic partnership to invest in sustainable businesses)[4]Applied Artificial Intelligence Corporation (partnership to bring AI to private equity investments)[4]Emergence Partners (Stanley invested as GP in automation and AI consulting firm forming part of its transformation team)[2]

Beyond the preview

Go deeper on Stanley Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stanley Capital Partners.

Explore the full profile